“It’s just another tool on my toolbelt”: New York state law enforcement officer experiences administering naloxone
Although naloxone is widely acknowledged as a life-saving intervention and a critical tool for first responders, there remains a need to explore how law enforcement officers have adapted to a shifting scope of... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - March 6, 2023 Category: Drugs & Pharmacology Authors: Danielle Lloyd, Kirsten Rowe, Shu-Yin John Leung, Elham Pourtaher and Kitty Gelberg Tags: Research Source Type: research
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa
Globally, 9% of people who inject drugs (PWID), a key hepatitis C-infected population, reside in sub-Saharan Africa. In South Africa, hepatitis C seroprevalence in PWID is high. It is almost 84% in Pretoria an... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - March 4, 2023 Category: Drugs & Pharmacology Authors: Elaine Saayman, Vanessa Hechter, Ndoliwe Kayuni and Mark W. Sonderup Tags: Research Source Type: research
“There’s absolutely no downside to this, I mean, except community opposition:” A qualitative study of the acceptability of vending machines for harm reduction
Vending machines for harm reduction (VMHR) are an innovative approach to deliver life-saving materials, information, and treatment for hard-to-reach populations, particularly for persons who inject drugs. The ... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 28, 2023 Category: Drugs & Pharmacology Authors: Rebecca E. Stewart, Nicholas C. Cardamone, Emily Loscalzo, Rachel French, Collin Lovelace, Winna Koe Mowenn, Ali Tarhini, Linden Lalley-Chareczko, Kathleen A. Brady and David S. Mandell Tags: Research Source Type: research
How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study
Naloxone is a medication that can quickly reverse an opioid overdose. Syringe service programs (SSPs) are community-based prevention programs that provide a range of evidence-based interventions in the USA, in... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 28, 2023 Category: Drugs & Pharmacology Authors: Barrot H. Lambdin, Lynn Wenger, Ricky Bluthenthal, Tyler S. Bartholomew, Hansel E. Tookes, Paul LaKosky, Savannah O ’Neill and Alex H. Kral Tags: Research Source Type: research
Puff, Puff, Don ’t Pass: harm reduction for cannabis use during a viral respiratory pandemic
Prior to the COVID-19 pandemic, cannabis use social practices often involved sharing prepared cannabis (joints/blunts/cigarettes) and cannabis-related paraphernalia. Previous studies have demonstrated that sha... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 25, 2023 Category: Drugs & Pharmacology Authors: Ryan D. Assaf, Marjan Javanbakht, Pamina M. Gorbach, Onyebuchi A. Arah, Steven J. Shoptaw and Ziva D. Cooper Tags: Research Source Type: research
Racial/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City
Drug overdose mortality is rising precipitously among Black people who use drugs. In NYC, the overdose mortality rate is now highest in Black (38.2 per 100,000) followed by the Latinx (33.6 per 100,000) and wh... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 25, 2023 Category: Drugs & Pharmacology Authors: Maria R. Khan, Lee Hoff, Luther Elliott, Joy D. Scheidell, John R. Pamplin II, Tarlise N. Townsend, Natalia M. Irvine and Alex S. Bennett Tags: Research Source Type: research
Motives for alcohol use, risky drinking patterns and harm reduction practices among people who experience homelessness and alcohol dependence in Montreal
People experiencing homelessness are disproportionately affected by harms related to alcohol use. Indeed, their alcohol dependence is associated with numerous physical and mental health problems along with str... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 24, 2023 Category: Drugs & Pharmacology Authors: Rossio Motta-Ochoa, Natalia Incio-Serra, Alexandre Brulotte and Jorge Flores-Aranda Tags: Research Source Type: research
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya
In sub-Saharan Africa many people who inject drugs (PWID) are living with undiagnosed or untreated HIV and experience high levels of poverty and conditions that can contribute to worse outcomes from SARS-CoV-2... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 23, 2023 Category: Drugs & Pharmacology Authors: Shradha Doshi, Hanley Kingston, Ashley S. Tseng, Bhavna H. Chohan, Betsy Sambai, Brandon L. Guthrie, Aliza Monroe-Wise, Loice W. Mbogo, Sarah Masyuko, Khai Hoan Tram, William Sinkele, Paul Macharia, David Bukusi, Joshua T. Herbeck and Carey Farquhar Tags: Research Source Type: research
‘I’m not going to leave someone to die’: carriage of naloxone by police in Scotland within a public health framework: a qualitative study of acceptability and experiences
Scotland has one of the highest rates of drug-related deaths (DRDs) per capita in Europe, the majority of which involve opioids. Naloxone is a medication used to reverse opioid-related overdoses. In efforts to... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 19, 2023 Category: Drugs & Pharmacology Authors: Elizabeth M. Speakman, Peter Hillen, Inga Heyman, Jennifer Murray, Nadine Dougall, Elizabeth V. Aston and Andrew McAuley Tags: Research Source Type: research
Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019 –2021: a repeat cross-sectional study
One of the objectives of cannabis legalization in Canada is to transition consumers from the illegal to the legal market. Little is known about how legal sourcing varies across different cannabis product types... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 17, 2023 Category: Drugs & Pharmacology Authors: Elle Wadsworth, Vicki Rynard, Pete Driezen, Tom P. Freeman, Marta Rychert, Chris Wilkins, Wayne Hall, Robert Gabrys and David Hammond Tags: Research Source Type: research
Factors associated with receptive injection equipment sharing among people who inject drugs: findings from a multistate study at the start of the COVID-19 pandemic
Receptive injection equipment sharing (i.e., injecting with syringes, cookers, rinse water previously used by another person) plays a central role in the transmission of infectious diseases (e.g., HIV, viral h... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 15, 2023 Category: Drugs & Pharmacology Authors: Sean T. Allen, Kristin E. Schneider, Miles Morris, Saba Rouhani, Samantha J. Harris, Brendan Saloner and Susan G. Sherman Tags: Research Source Type: research
Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
Despite the widespread availability of naloxone, US opioid overdose rates continue to rise. The “Cascade of Care” (CoC) is a public health approach that identifies steps in achieving specific outcomes and has ... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 14, 2023 Category: Drugs & Pharmacology Authors: Zofia Kozak, Daniel Ciccarone, Johannes Thrul, Thomas O. Cole, Alexander L. Pappas, Aaron D. Greenblatt, Christopher Welsh, Mark Yoon, Donald Gann Jr., E. Erin Artigiani, Eric D. Wish and Annabelle M. Belcher Tags: Brief Report Source Type: research
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery
The World Health Organization (WHO) recommends oral pre-exposure prophylaxis (PrEP) for all people at substantial risk of HIV as part of combination prevention. The extent to which this recommendation has been... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 13, 2023 Category: Drugs & Pharmacology Authors: Graham Shaw, Robin Schaefer, Heather-Marie A Schmidt, Annie Madden, Judy Chang, Antons Mozalevskis, Busisiwe Msimanga-Radebe, Nabeel Mangadan Konath, Annette Verster, Rachel Baggaley, Michelle Rodolph and Virginia Macdonald Tags: Perspective Source Type: research
Need for integration of hepatitis C (HCV) services in community-based settings for people who inject drugs: results from a global values and preferences survey
To inform the development of updated World Health Organization (WHO) guidelines on simplified service delivery for HCV infection, a global survey was undertaken among people affected or infected by HCV. The ob... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 9, 2023 Category: Drugs & Pharmacology Authors: M. Di Ciaccio, V. Villes, C. Perfect, J. L. El Kaim, M. Donatelli, C. James, P. Easterbrook and R. M. Delabre Tags: Research Source Type: research
Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation
The ongoing COVID-19 pandemic has disproportionately affected structurally vulnerable populations including people who use drugs (PWUD). Increased overdose risk behaviors among PWUD during the pandemic have be... (Source: Harm Reduction Journal)
Source: Harm Reduction Journal - February 4, 2023 Category: Drugs & Pharmacology Authors: Lisa Frueh, Alexandra B. Collins, Roxxanne Newman, Nancy P. Barnett, Josiah D. Rich, Melissa A. Clark, Brandon D. L. Marshall and Alexandria Macmadu Tags: Research Source Type: research
